» Articles » PMID: 29761723

Knowledge and Attitudes Regarding HPV and Vaccination Among Chinese Women Aged 20 to 35 Years in Fujian Province: A Cross-Sectional Study

Overview
Journal Cancer Control
Specialty Oncology
Date 2018 May 16
PMID 29761723
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

The use of the human papillomavirus (HPV) vaccine was recently approved in Mainland China. This study determined the knowledge and attitudes of young women aged 20 to 35 years in Fujian Province, China, with regard to HPV and vaccination and explored the potential factors influencing their attitudes toward HPV vaccination. This was a cross-sectional study that collected data regarding the knowledge on and attitudes toward HPV and vaccination using questionnaires. Furthermore, the prevalence of HPV was determined from the sampled participants. A total of 1001 young women were included in the survey. This study demonstrated that the HPV prevalence rate was 15.7% (157/1001). Among all patients, 44.9% (n = 449) had heard of HPV; however, detailed knowledge about HPV was lacking. The majority (83.7%) expressed a willingness to be vaccinated. Specifically, knowledge of the dangers of HPV infection was significantly associated with the willingness to be vaccinated. In this study, women cited some concerns and expressed high expectations for the HPV vaccine, but the costs of vaccination reduced their willingness to be vaccinated. This study found that most patients did not have a detailed knowledge of HPV. Thus, there is a need for continued HPV promotion and education efforts, especially on the dangers of HPV infection, among young women aged 20 to 35 years in Fujian Province, China. Furthermore, it is important to subsidize the costs of vaccination for promoting vaccination campaigns in China.

Citing Articles

Analysis of high-risk human papillomavirus infections and cervical intraepithelial neoplasia: factors influencing awareness among women of childbearing age in southwest China.

Ning K, Gong J, Li X, He L Prim Health Care Res Dev. 2024; 25:e41.

PMID: 39370943 PMC: 11464798. DOI: 10.1017/S1463423624000331.


Strategies to eliminate cervical cancer in China.

Ji L, Chen M, Yao L Front Oncol. 2023; 13:1105468.

PMID: 37333817 PMC: 10273099. DOI: 10.3389/fonc.2023.1105468.


Knowledge, attitudes, and perceptions associated with HPV vaccination among female Korean and Chinese university students.

Kim H, Lee E, Lee Y, Kim S, Jin Y, Kim Y BMC Womens Health. 2022; 22(1):51.

PMID: 35197031 PMC: 8867647. DOI: 10.1186/s12905-022-01624-1.


The prevalence of human papillomavirus and bacterial vaginosis among young women in China: a cross-sectional study.

Lin W, Zhang Q, Chen Y, Chen L, Dong B, Sun P BMC Womens Health. 2021; 21(1):409.

PMID: 34886845 PMC: 8662885. DOI: 10.1186/s12905-021-01504-0.


Promoting HPV vaccination on social media: interactive effects of threat, efficacy and social cues.

Chen L, Yang X, Huang X Hum Vaccin Immunother. 2021; 17(11):4442-4456.

PMID: 34623229 PMC: 8828094. DOI: 10.1080/21645515.2021.1975449.


References
1.
Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M . Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2014; 136(5):E359-86. DOI: 10.1002/ijc.29210. View

2.
Kwan T, Chan K, Yip A, Tam K, Cheung A, Young P . Barriers and facilitators to human papillomavirus vaccination among Chinese adolescent girls in Hong Kong: a qualitative-quantitative study. Sex Transm Infect. 2008; 84(3):227-32. DOI: 10.1136/sti.2007.029363. View

3.
Hu S, Hong Y, Zhao F, Lewkowitz A, Chen F, Zhang W . Prevalence of HPV Infection And Cervical Intraepithelial Neoplasia And Attitudes towards HPV Vaccination among Chinese Women Aged 18-25 in Jiangsu Province. Chin J Cancer Res. 2013; 23(1):25-32. PMC: 3587523. DOI: 10.1007/s11670-011-0025-3. View

4.
Belinson J, Qiao Y, Pretorius R, Zhang W, Elson P, Li L . Shanxi Province Cervical Cancer Screening Study: a cross-sectional comparative trial of multiple techniques to detect cervical neoplasia. Gynecol Oncol. 2001; 83(2):439-44. DOI: 10.1006/gyno.2001.6370. View

5.
Wigle J, Coast E, Watson-Jones D . Human papillomavirus (HPV) vaccine implementation in low and middle-income countries (LMICs): health system experiences and prospects. Vaccine. 2013; 31(37):3811-7. PMC: 3763375. DOI: 10.1016/j.vaccine.2013.06.016. View